Orthofix International | OFIX - 营业费用

金融业

USD 9.59

USD 873.02M

现金及等价物

USD 103.81M

USD 66.63M

USD 446.13M

USD 157.01M

USD 137.24M

股息收益率

0

USD 6.12M

USD 27.88M

1.09K

EPS每股收益

USD 0.09

股本和储备

USD 429.18M

USD 153.28M

债务利息支出

4.68M

USD 221.59M

USD 362.8M

USD -2.22M

USD 213.79M

USD 6.12M

普通股股本

USD 39.83M

4.17K

USD -2.19M

USD 219.91M

销售和管理费用

USD 130.35M

USD 184.48M

贸易债权人

USD 63.53M

应收帐款人

USD 135.75M

	营业费用	更改		日
Accuray	USD 37.18M		567K	2024-12
AngioDynamics	USD 81.95M		1.68M	2025-09
Artivion	USD 111.2M		9.45M	2025-12
AtriCure	USD 143.94M		3.22M	2026-06
Dexcom	USD 990.1M		53.5M	2026-06
EDAP TMS	EUR 25.18M		6.37M	2026-03
Globus Medical	USD 835.58M		239.73M	2026-06
Inogen	USD 49.14M		665K	2024-09
Insulet	USD 672M		32.3M	2026-06
Integra LifeSciences	USD 1.04B		971K	2026-06
J&J	USD 18.93B		1.09B	2026-09
Medtronic	USD 7.92B		203M	2026-06
Mesa Laboratories	USD 33.98M		2.03M	2024-12
Orthofix International	USD 213.79M		12.36M	2025-12
Plus Therapeutics	USD 8.15M		1.04M	2026-03
Smith & Nephew	USD 2.59B		71M	2026-06
STAAR Surgical	USD 83.43M		7.32M	2026-06
Stryker	USD 4.8B		118M	2026-06
Tandem Diabetes Care	USD 268.35M		3.7M	2026-06
Teleflex	USD 2.9B		179.9M	2026-06
Veracyte	USD 126.36M		6.37M	2026-06
Zimmer Biomet Holdings	USD 1.83B		140.7M	2026-06